Skip to main content
. 2018 Apr 4;23(4):832. doi: 10.3390/molecules23040832

Table 2.

Distribution of rs1412125 and rs1360485 and lung cancer risk.

Genotype Cases (%) Controls (%) OR(95% CI) * p-Value HWE
rs1412125 0.529
TT 511 (60.1%) 396 (54.0%) 1
CT 296 (34.8%) 290 (39.6%) 0.744(0.599, 0.924) 0.008
CC 43 (5.1%) 47 (6.4%) 0.684 (0.434, 1.077) 0.101
Dominant model
TT 511 (60.1%) 396 (54.0%) 1 0.004
CT + CC 339 (39.9%) 337 (46.0%) 0.736 (0.597, 0.906)
Recessive model
TT + CT 807 (94.9%) 686 (93.6%) 1 0.247
CC 43 (5.1%) 47 (6.4%) 0.769 (0.493, 1.200)
Allele model
T allele 1318 (77.5%) 1082 (73.8%) 1 0.102
C allele 382 (22.5%) 384 (26.2%) 0.769 (0.561, 1.053)
rs1360485 0.945
AA 579 (68.1%) 464 (63.3%) 1
AG 245 (28.8%) 238 (32.5%) 0.836 (0.668, 1.046) 0.117
GG 26 (3.1%) 31 (4.2%) 0.667 (0.381, 1.168) 0.157
Dominant model
AA 579 (68.1%) 464 (63.3%) 1 0.066
AG + GG 271 (31.9%) 269 (36.7%) 0.816 (0.658, 1.013)
Recessive model
AA + AG 824 (96.9%) 702 (95.8%) 1 0.219
GG 26 (3.1%) 31 (4.2%) 0.706 (0.405, 1.231)
Allele model
A allele 1403 (82.5%) 1166 (79.5%) 1 0.047
G allele 297 (17.5%) 300 (20.5%) 0.829 (0.689, 0.998)

HWE, Hardy-Weinberg equilibrium; OR, Odd ratio; 95% CI, 95% Confidence Interval; *OR was adjusted by age, gender and smoking.